Wedbush Maintains Neutral on Sionna Therapeutics, Raises Price Target to $6

Benzinga Newsdesk www.benzinga.com Positive 52.3%

Neg 0% Neu 0% Pos 52.3%

Wedbush analyst Laura Chico maintains Sionna Therapeutics (NASDAQ:SION) with a Neutral and raises the price target from $5 to $6.